Stocks to Watch: Dropbox, Nike, Tronc, Qualcomm, Puma Biotechnology, Invitation Homes, Universal Display - WSJ
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
Articles with Puma Biotechnology
Puma Biotechnology
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology (PBYI) Q1 Earnings: Stock To Disappoint? | Investing.com
Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity - Market Exclusive
Video Puma Biotechnology Soars on Breast Cancer Drug Results - ABC News
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Supernus, Puma Among 5 Big Biotech Stock Winners, Losers Monday | Stock News & Stock Market Analysis - IBD
PBYI Institutional Ownership and Shareholders - Puma Biotechnology Inc (NASDAQ) Stock
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | The Motley Fool
Puma Biotechnology Inc. (PBYI) Stock Price, Quote & News - Stock Analysis
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotech News, Puma Biotech Quote, PBYI Quote - StreetInsider.com
Puma Biotechnology: A Speculative Investment At A Discount (NASDAQ:PBYI) | Seeking Alpha
Why Puma Biotechnology Is Soaring Today | The Motley Fool
Puma Biotechnology: Risky Investment (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
Buy Puma Biotechnology Inc stock & View ($PBYI) Share Price on eToro.
News Release
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
